Stay updated on Olaparib Response in BRCA Methylation Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Olaparib Response in BRCA Methylation Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Olaparib Response in BRCA Methylation Breast Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page has been updated to version v2.16.5, and the previous version v2.16.4 has been removed from the content. Additionally, a significant note regarding the modernization of ClinicalTrials.gov data ingest scheduled for July 2025 has been deleted.
    Difference
    0.7%
    Check dated 2025-07-04T04:11:52.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The expected modernization date for the ClinicalTrials.gov data ingest has been pushed back from June 2025 to July 2025.
    Difference
    0.6%
    Check dated 2025-06-19T20:06:15.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.0%
    Check dated 2025-06-05T11:26:57.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.
    Difference
    0.9%
    Check dated 2025-05-29T06:15:08.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.0%
    Check dated 2025-04-30T14:26:31.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    The webpage has undergone significant changes, including the removal of detailed eligibility criteria and study descriptions for a clinical trial on olaparib in advanced breast cancer, while adding new identifiers and collaborators related to the study.
    Difference
    46%
    Check dated 2025-04-16T11:20:57.000Z thumbnail image

Stay in the know with updates to Olaparib Response in BRCA Methylation Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Olaparib Response in BRCA Methylation Breast Cancer Clinical Trial page.